Interleukin-6 Receptor Antagonist [EPC] - N0000190480

Pharmacologic Code	N0000190480
Pharmacologic Name	Interleukin-6 Receptor Antagonist
Pharmacologic Uses	interleukin-6 (IL-6) receptor antagonist
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 9 products whose active ingredient are classified under the same pharmacologic class Interleukin-6 Receptor Antagonist [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0024-5908	Kevzara	Non-Proprietary Name: Sarilumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	ACTIVE
	0024-5910	Kevzara	Non-Proprietary Name: Sarilumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	ACTIVE
	0024-5920	Kevzara	Non-Proprietary Name: Sarilumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	ACTIVE
	0024-5922	Kevzara	Non-Proprietary Name: Sarilumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	ACTIVE
	50242-135	Actemra	Non-Proprietary Name: Tocilizumab	Injection, Solution, Concentrate	Intravenous	Genentech, Inc.	ACTIVE
	50242-136	Actemra	Non-Proprietary Name: Tocilizumab	Injection, Solution, Concentrate	Intravenous	Genentech, Inc.	ACTIVE
	50242-137	Actemra	Non-Proprietary Name: Tocilizumab	Injection, Solution, Concentrate	Intravenous	Genentech, Inc.	ACTIVE
	50242-138	Actemra	Non-Proprietary Name: Tocilizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-143	Actemra Actpen	Non-Proprietary Name: Tocilizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE